Changes in plaque lipid content after short-term intensive versus standard statin therapy: The YELLOW trial (Reduction in Yellow Plaque by Aggressive Lipid-Lowering Therapy)

Journal of the American College of Cardiology

Volumn 62, Issue 1, 2013, Pages 21-29

  Kini, Annapoorna S ^a   Baber, Usman ^a   Kovacic, Jason C ^a   Limaye, Atul ^a   Ali, Ziad A ^a   Sweeny, Joseph ^a   Maehara, Akiko ^b   Mehran, Roxana ^a,b   Dangas, George ^a,b   Mintz, Gary S ^b   Fuster, Valentin ^a,c   Narula, Jagat ^a   Sharma, Samin K ^a   Moreno, Pedro R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

plaque modification; regression; spectroscopy; statins; vulnerable plaque

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLEEDING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FRACTIONAL FLOW RESERVE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTRAVASCULAR ULTRASOUND; LIPID COMPOSITION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MYALGIA; NEAR INFRARED SPECTROSCOPY; PRIORITY JOURNAL; RHABDOMYOLYSIS; SHORT COURSE THERAPY; SIDE EFFECT; THORAX PAIN;

AGED; CORONARY ARTERY DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 84879384936     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.03.058     Document Type: Article

References (35)

1. W.S. Weintraub, S.R. Daniels, and L.E. Burke Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association Circulation 124 2011 967 990
2. S.C. Smith Jr., E.J. Benjamin, and R.O. Bonow AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation J Am Coll Cardiol 58 2011 2432 2446
3. R. Bulbulia, L. Bowman, and K. Wallendszus Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial Lancet 378 2011 2013 2020
4. U. Schonbeck, and P. Libby Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 109 2004 II18 II26
5. S.J. Nicholls, C.M. Ballantyne, and P.J. Barter Effect of two intensive statin regimens on progression of coronary disease N Engl J Med 365 2011 2078 2087
6. S.J. Nicholls, A. Hsu, and K. Wolski Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome J Am Coll Cardiol 55 2010 2399 2407
7. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes (1) N Engl J Med 326 1992 242 250
8. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes (2) N Engl J Med 326 1992 310 318
9. G.W. Stone, A. Maehara, and A.J. Lansky A prospective natural-history study of coronary atherosclerosis N Engl J Med 364 2011 226 235
10. V. Fuster, Z.A. Fayad, P.R. Moreno, M. Poon, R. Corti, and J.J. Badimon Atherothrombosis and high-risk plaque: part II: approaches by noninvasive computed tomographic/magnetic resonance imaging J Am Coll Cardiol 46 2005 1209 1218 (Pubitemid 41615539)
11. P.R. Moreno The high-risk thin-cap fibroatheroma: a new kid in the block Circ Cardiovasc Interv 2 2009 500 502
12. A. Fernandez-Ortiz, J.J. Badimon, and E. Falk Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture J Am Coll Cardiol 23 1994 1562 1569 (Pubitemid 24182120)
13. I. Bot, J.W. Jukema, I.M. Lankhuizen, T.J. van Berkel, and E.A. Biessen Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels Atherosclerosis 214 2011 295 300
14. M. Puato, E. Faggin, and M. Rattazzi Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy Stroke 41 2010 1163 1168
15. X.Q. Zhao, L. Dong, and T. Hatsukami MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course J Am Coll Cardiol Img 4 2011 977 986
16. P.R. Moreno, and A. Kini Resolution of inflammation, statins, and plaque regression J Am Coll Cardiol Img 5 2012 178 181
17. T. Kubo, A. Maehara, and G.S. Mintz The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization J Am Coll Cardiol 55 2010 1590 1597
18. K. Inoue, S. Motoyama, and M. Sarai Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention J Am Coll Cardiol Img 3 2010 691 698
19. K. Hattori, Y. Ozaki, and T.F. Ismail Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS J Am Coll Cardiol Img 5 2012 169 177
20. M.J. Suter, S.K. Nadkarni, and G. Weisz Intravascular optical imaging technology for investigating the coronary artery J Am Coll Cardiol Img 4 2011 1022 1039
21. P.A. Tonino, B. De Bruyne, and N.H. Pijls Fractional flow reserve versus angiography for guiding percutaneous coronary intervention N Engl J Med 360 2009 213 224
22. G.S. Mintz, S.E. Nissen, and W.D. Anderson American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents J Am Coll Cardiol 37 2001 1478 1492
23. J.A. Goldstein, B. Maini, and S.R. Dixon Detection of lipid-core plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction Circ Cardiovasc Interv 4 2011 429 437
24. J. Pu, G.S. Mintz, and E.S. Brilakis In vivo characterization of coronary plaques: novel findings from comparing greyscale and virtual histology intravascular ultrasound and near-infrared spectroscopy Eur Heart J 33 2012 372 383
25. W.J. Conover, and R.L. Iman Analysis of covariance using the rank transformation Biometrics 38 1982 715 724 (Pubitemid 13286346)
26. C.M. Gardner, H. Tan, and E.L. Hull Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system J Am Coll Cardiol Img 1 2008 638 648
27. S.E. Nissen, E.M. Tuzcu, and P. Schoenhagen Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial JAMA 291 2004 1071 1080 (Pubitemid 38541684)
28. S.E. Nissen, S.J. Nicholls, and I. Sipahi Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 2006 1556 1565
29. W.E. Boden, R.A. O'Rourke, and K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516 (Pubitemid 46588415)
30. P.R. Moreno, and J.E. Muller Identification of high-risk atherosclerotic plaques: a survey of spectroscopic methods Curr Opin Cardiol 17 2002 638 647 (Pubitemid 36084263)
31. P.R. Moreno, R.A. Lodder, K.R. Purushothaman, W.E. Charash, W.N. O'Connor, and J.E. Muller Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy Circulation 105 2002 923 927 (Pubitemid 34184568)
32. S. Tsimikas, J.L. Witztum, and E.R. Miller High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial Circulation 110 2004 1406 1412 (Pubitemid 39238018)
33. K.K. Ray, C.P. Cannon, and C.H. McCabe Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial J Am Coll Cardiol 46 2005 1405 1410 (Pubitemid 41446173)
34. D. Altman Comparability of randomised groups J R Stat Soc Ser D 34 1985 125 136
35. L. Wei, and J. Zhang Analysis of data with imbalance in the baseline outcome variable for randomized clinical trials Drug Inf J 35 2001 1201 1214 (Pubitemid 34563414)